Goldman Sachs’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.7M Buy
777,940
+125,422
+19% +$4.96M ﹤0.01% 1462
2025
Q1
$19.7M Buy
652,518
+274,310
+73% +$8.28M ﹤0.01% 1715
2024
Q4
$13.2M Buy
378,208
+142,498
+60% +$4.98M ﹤0.01% 2121
2024
Q3
$9.44M Sell
235,710
-92,595
-28% -$3.71M ﹤0.01% 2310
2024
Q2
$15.6M Buy
328,305
+127,925
+64% +$6.1M ﹤0.01% 1752
2024
Q1
$8.69M Sell
200,380
-181,002
-47% -$7.85M ﹤0.01% 2159
2023
Q4
$19.3M Buy
381,382
+43,555
+13% +$2.2M ﹤0.01% 1596
2023
Q3
$15.3M Buy
337,827
+149,455
+79% +$6.78M ﹤0.01% 1679
2023
Q2
$7.73M Sell
188,372
-233,726
-55% -$9.59M ﹤0.01% 2238
2023
Q1
$15.1M Sell
422,098
-500,313
-54% -$17.9M ﹤0.01% 1718
2022
Q4
$34.8M Sell
922,411
-368,154
-29% -$13.9M 0.01% 1204
2022
Q3
$57.1M Buy
1,290,565
+248,741
+24% +$11M 0.01% 893
2022
Q2
$38.6M Buy
1,041,824
+87,498
+9% +$3.24M 0.01% 1126
2022
Q1
$35.3M Buy
954,326
+365,028
+62% +$13.5M 0.01% 1336
2021
Q4
$17.9M Sell
589,298
-12,538
-2% -$382K ﹤0.01% 1828
2021
Q3
$20.2M Sell
601,836
-77,593
-11% -$2.6M ﹤0.01% 1725
2021
Q2
$27.1M Sell
679,429
-65,481
-9% -$2.61M 0.01% 1513
2021
Q1
$33.5M Sell
744,910
-299,144
-29% -$13.4M 0.01% 1293
2020
Q4
$59M Buy
1,044,054
+453,994
+77% +$25.7M 0.02% 852
2020
Q3
$28M Sell
590,060
-173,718
-23% -$8.24M 0.01% 1258
2020
Q2
$45M Buy
763,778
+44,028
+6% +$2.6M 0.01% 925
2020
Q1
$34M Buy
719,750
+184,724
+35% +$8.73M 0.01% 1012
2019
Q4
$32.3M Sell
535,026
-35,203
-6% -$2.13M 0.01% 1300
2019
Q3
$34.2M Sell
570,229
-918,846
-62% -$55M 0.01% 1209
2019
Q2
$95.7M Buy
1,489,075
+997,199
+203% +$64.1M 0.03% 642
2019
Q1
$39.9M Sell
491,876
-693,876
-59% -$56.3M 0.01% 1159
2018
Q4
$64.1M Sell
1,185,752
-409,723
-26% -$22.1M 0.02% 802
2018
Q3
$82.3M Sell
1,595,475
-69,548
-4% -$3.59M 0.02% 801
2018
Q2
$69.4M Sell
1,665,023
-290,944
-15% -$12.1M 0.02% 896
2018
Q1
$86.2M Buy
1,955,967
+27,069
+1% +$1.19M 0.02% 786
2017
Q4
$97M Buy
1,928,898
+242,041
+14% +$12.2M 0.02% 703
2017
Q3
$85.5M Buy
1,686,857
+221,721
+15% +$11.2M 0.02% 769
2017
Q2
$74.5M Buy
1,465,136
+728,147
+99% +$37M 0.02% 830
2017
Q1
$29.6M Buy
736,989
+44,372
+6% +$1.78M 0.01% 1311
2016
Q4
$33.1M Sell
692,617
-367,521
-35% -$17.6M 0.01% 1222
2016
Q3
$38.8M Buy
1,060,138
+53,132
+5% +$1.95M 0.01% 1106
2016
Q2
$23.5M Buy
1,007,006
+329,683
+49% +$7.68M 0.01% 1321
2016
Q1
$27.4M Sell
677,323
-719,909
-52% -$29.2M 0.01% 1215
2015
Q4
$86.5M Buy
1,397,232
+262,275
+23% +$16.2M 0.03% 600
2015
Q3
$45.9M Buy
1,134,957
+193,475
+21% +$7.82M 0.02% 858
2015
Q2
$54.2M Sell
941,482
-166,715
-15% -$9.59M 0.02% 816
2015
Q1
$70.6M Buy
1,108,197
+658,798
+147% +$41.9M 0.02% 662
2014
Q4
$27.7M Sell
449,399
-326,906
-42% -$20.2M 0.01% 1149
2014
Q3
$30.1M Sell
776,305
-273
-0% -$10.6K 0.01% 1058
2014
Q2
$26.8M Buy
776,578
+212,583
+38% +$7.32M 0.01% 1131
2014
Q1
$24.4M Sell
563,995
-24,394
-4% -$1.05M 0.01% 1139
2013
Q4
$23.4M Buy
588,389
+60,587
+11% +$2.41M 0.01% 1131
2013
Q3
$19.8M Buy
527,802
+90,102
+21% +$3.38M 0.01% 1126
2013
Q2
$11.8M Buy
+437,700
New +$11.8M ﹤0.01% 1293